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Abstract
The heart is one of the organs affected during the later stages of diabetes. Mitochondrial function has already been proposed
to be affected during the course of diabetes. Nevertheless, little information is known concerning the impact of antioxidants in
heart mitochondria of a milder model for diabetes, such as the Goto-Kakizaki (GK) rat, where mitochondrial function appears
ameliorated. The objective of this work was to test if injections of Vitamin E and Coenzyme Q10, alone and in combination,
were able to modify mitochondrial performance in the hearts of GK rats.
Several aspects of mitochondrial function were measured, such as the respiratory control ratio and the electric potential, as
well as the mitochondrial accumulation of Vitamin E and Coenzymes Q9 and Q10. We observed that only Vitamin E appeared
to have a positive impact on the mitochondrial phosphorylation efficiency and on mitochondrial performance, namely on
the ability to generate the electric transmembrane potential in the presence of supra-physiological calcium concentrations.
Vitamin E administration also increased the mitochondrial concentration of Coenzyme Q10. None of the treatments was able to
reverse the diabetic phenotype in GK rats. We conclude that in this model of mild hyperglycemia, administration of
antioxidants may have a marginal positive impact on mitochondrial function.
q 2004 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
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1. Introduction
Diabetes mellitus is one of the most common
metabolic diseases. The complications associated
with this condition are often responsible for
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a decreased quality of life in many patients. Mortality
in the diabetic population is primarily due to
cardiovascular disease, which is not dissimilar from
the non-diabetic population. However, the diabetic
population has a greater probability to suffer from
cardiovascular problems and heart failure than the
general population (Pierce et al., 1997; Chaudhuri and
Hopkins, 2000). The cardiovascular mortality rate is
more than doubled in men and more than quadrupled
in women with diabetes when compared with their
non-diabetic counterparts. Mechanisms leading to
vascular perturbations such as atherosclerosis (King
and Wakasaki, 1999) have been proposed to explain
the complications associated with this pathology
(Chaudhuri and Hopkins, 2000). Endothelial dysfunc-
tion associated with diabetes may lead to impaired
vasodilatation, causing vascular and cardiac dysfunc-
tion (De Vriese, 2000).
Mitochondria, being cellular powerhouses, can
play a dual role in diabetic pathology. Mutations in
the mitochondrial DNA are associated with the
development of diabetes (Gerbitz et al., 1996;
Perucca-Lostanlen et al., 2000) and diabetes was itself
shown to modify mitochondrial function (Kristal et al.,
1997). Functional mitochondria in pancreatic b-cells
are needed to provide the necessary ATP to sustain
insulin release into blood (Gerbitz et al., 1995;
Anderson, 1999), thus illustrating the importance of
mitochondrial bioenergetics in the process of diabetes.
Type 2 (non-insulin dependent diabetes mellitus—
NIDDM) is one of the most common metabolic
diseases in man. The development of model animals
carrying this pathology is also of crucial importance to
study the biochemical changes observed at the
organism level. The Goto-Kakizaki (GK) rat has
been designed as a NIDDM model (Goto et al., 1975,
1988) and used in several metabolic studies related to
this pathology.
Surprisingly, previous studies with GK rats showed
an improvement of hepatic mitochondrial bioener-
getics (Ferreira et al., 1999a,b) and mitochondrial
antioxidant capacity, including increased levels of
vitamin E (Ferreira et al., 1999c), suggesting specific
changes in mitochondria. It appears that those
modifications acted as an adaptation to the hyper-
glycemic condition. Previous work has also described
an enhanced calcium loading capacity in heart
mitochondria from GK rats (Oliveira et al., 2001).
Diabetes and associated complications are often
associated with increased oxidative stress (Baynes,
1991; Baynes and Thorpe, 2000; Schmidt and Stern,
2000). Extensive literature has debated the use of
antioxidants to counteract some complications
associated with the hyperglycemic condition.
Coenzyme Q (CoQ) or ubiquinone (2,3,-dimethoxy-
5-methyl-6-multiprenyl-1,2-benzoquinone) is a
redox-active and lipophilic substance present in
most cellular membranes. It consists of a quinone
head attached to a chain of isoprene units numbering
9 or 10 (CoQ9 or CoQ10) in the different mammal
species. CoQ plays several roles in cells. Probably,
the most well known function of CoQ in cells is
electron transfer in the mitochondrial electron
transport chain. Coenzyme Q is able to transfer
electrons from Complex I or II to Complex III
(Ernster and Dallner, 1995). Furthermore, its reduced
form was proposed as an antioxidant (Ernster and
Dallner, 1995). It was previously described that
coenzyme Q10 administration was able to decrease
protein oxidation and increase the antioxidant
potential in the rat (Lamson and Plaza, 2002).
Some reports also confirmed some clinical advantage
of coenzyme Q against diabetes-derived compli-
cations (for a review see Lamson and Plaza, 2002).
Vitamin E (a-tocopherol, VitE) is the major
lipid soluble chain-breaking antioxidant found in
the plasma and tissues (Burton and Traber, 1990).
A joint action of both coenzyme Q and vitamin E
against cellular oxidative damage has also been
proposed (Kagan et al., 1990).
By using an animal model for a mild form of
diabetes, the GK rat, we investigated whether CoQ10,
VitE or both compounds together could indeed
ameliorate cardiac mitochondrial function. So far,
no report in the literature is available concerning the
possible benefits of such treatments in a mitochondrial
population that appears to have enhanced functions in
this model for mild hyperglycemia.
2. Materials and methods
2.1. Materials
All reagents and chemicals used were of the
highest grade of purity commercially available.
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CoQ10 and VitE were dissolved in soybean oil
(Sigma S7381) prior to in vivo injections.
2.2. Animals
Male GK rats (4 weeks) were maintained in our
local colony (Laboratory Animal Research Center,
University Hospitals, Coimbra) with ad libitum access
to food (AO4-Panlab, Spain)) and water at pH 4.5.
Room temperature was kept at 22–24 8C and the
moisture at 50–60%. The animals were subjected to a
12 h day/night cycle. The research procedure was
carried out in accordance with the European Require-
ment for Vertebrate Animal Research.
2.3. Animal treatment
GK rats were randomly divided into four groups:
Soybean Oil alone (2 ml/Kg i.p., control), Vitamin E
(200 mg/Kg, i.p., VitE), Coenzyme Q10 (20 mg/Kg,
i.p., CoQ10) and Coenzyme Q10 þ Vitamin E
(200 mg/Kg, i.p.VitE plus 20 mg/Kg, i.p. CoQ10
CoQ10 þ VitE). There were no statistically signifi-
cant differences concerning initial body weights
between the four experimental groups.
2.4. Biochemical analyses
Animals were injected three times a week during
seven weeks. Initial evaluations were performed
before the start of the treatment. Final evaluations
were conducted 24 h after the last injection. Blood
glucose concentration (occasional glucose) was
determined from the tail vein using a commercial
glucometer (Glucometer-Elite, Bayer). The glycated
hemoglobin (HbA1c) was determined at the time of
sacrifice through ionic exchange chromatographic
assay (Abbott IMx Glicohemoglobin, Abbott Labora-
tories, Portugal).
2.5. Isolation of mitochondria from rat heart
Twenty four hours after last injection, animals
were sacrificed and their heart excised. Rat heart
mitochondria were prepared as previously described
(Oliveira et al., 2000). Mitochondrial protein
content was determined by the biuret method
calibrated with BSA.
2.6. Measurement of mitochondrial transmembrane
potential
The mitochondrial transmembrane potential ðDCÞ
was estimated with a tetraphenylphosphonium cation
(TPPþ) electrode according to the equation of Kamo
et al. (1979), without correction for the ‘passive’
binding contribution of TPPþ to the mitochondrial
membranes (as the purpose of the experiment was to
show relative changes in the potential rather than
absolute values). A matrix volume of 1.1 ml/mg
protein was assumed and valinomycin was used to
calibrate the basal line. Reactions were carried out at
25 8C in 1 ml of the reaction media (200 mM sucrose,
10 mM Tris-Mops, 10 mM EGTA, 5 mM KH2PO4
and 2 mM rotenone, pH 7.4) supplemented with 1 mM
TPPþ and 0.5 mg of mitochondria. Mitochondria
were energized with 8 mM succinate. ADP-induced
depolarization was calculated as the maximum
difference observed in membrane potential measured
after ADP addition. Phosphorylation lag phase was
measured as the time in seconds the mitochondrial
suspension took to phosphorylate the added ADP (that
is, the time between mitochondrial depolarization and
repolarization).
2.7. TPPþ uptake in the presence of calcium
Mitochondrial TPPþ uptake was performed using a
TPPþ-selective electrode, using a AgCl reference
electrode. Mitochondrial protein (0.5 mg) was sus-
pended in 2 ml of reaction buffer (200 mM sucrose,
10 mM TRIS-MOPS, 10 mM EGTA and 5 mM
KH2PO4, pH 7.4, 25 8C), supplemented with 2 mM
rotenone and 0.5 mM TPPþ. Sequential additions of
0.5 mM TPPþ were made in order to calibrate the
system. Succinate was added to the mitochondrial
suspension after a total of 3 mM TPPþ in the buffer, in
the presence of 100 mM calcium. In each assay, the
calibration was used to calculate the TPPþ accumu-
lated inside mitochondria in the presence of calcium.
Succinate was the substrate used as this allowed a
fully reduced pool of pyridine nucleotides.
2.8. Mitochondrial oxygen consumption
Oxygen consumption of isolated heart mitochondria
was monitored polarographically with a Clark oxygen
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electrode connected to a suitable recorder simul-
taneously with the DC measurement. Reactions were
carried out, at 25 8C, in 1 ml of the reaction media
composed by 200 mM sucrose, 10 mM Tris-Mops,
10 mM EGTA, 5 mM KH2PO4 and 2 mM rotenone,
pH 7.4. Mitochondria were suspended at a concen-
tration of 0.5 mg/ml in the respiratory medium and
energized with 8 mM succinate. This substrate was
used in order to avoid possible artifacts related to loss
of activity of complex I during mitochondrial
isolation. ADP (100 nmol) was added to induce state
3 respiration. The Respiratory Control Ratio (RCR)
was calculated as the ratio between state 3 and state 4
respiration. The ADP/O was calculated as the number
of nmol ADP phosphorylated by natom oxygen
consumed.
2.9. Extraction and quantification of CoQ9, CoQ10,
and vitamin E
Aliquots of mitochondria containing 1 mg of
protein/ml were extracted according to the method
described by Takada et al. (1984). The extract was
evaporated to dryness under a stream of N2 and
resuspended in absolute ethanol. CoQ content was
determined by reverse-phase HPLC (Spherisorb
RP18, S5ODS2 column). Samples were eluted
with methanol:heptane (10:2 vol/vol) at a flow rate
of 2 ml/min. Detection was performed by an ultra-
violet (UV) detector at 269 nm. Vitamin E was
extracted and quantified by following the method
described by Takayanagi et al. (1980). The extract
was evaporated to dryness under a stream of N2 and
resuspended in n-hexane. Vitamin E content was
determined by reverse-phase HPLC (4.6 £ 200 mm;
Spherisorb S10w column). Samples were eluted with
n-hexane supplemented with 0.9% methanol at a flow
rate of 1.5 ml/min. Detection was performed by a UV
detector at 287 nm.
2.10. Statistical analysis
The results are presented as the mean ^ SEM of
5–8 independent experiments. Statistical analysis was
performed by using One Way Analysis of Variance
(ANOVA) and the Dunnet pos-test. A P value ,0.05
was considered statistically significant.
3. Results
Table 1 presents the data regarding animal weight
determination and biochemical analyses of occasional
glycemia and glycated hemoglobin. As seen, none of
the treatment groups was significantly different from
the control group (vehicle-injected rats). At the time
of sacrifice, normal (non-diabetic) Wistar rats of the
same age showed occasional glycemia values of
84 ^ 2 mg/dl and glycated hemoglobin values of
5.26 ^ 0.09%, thus showing that GK rats used in this
study suffered from a mild form of hyperglycemia
(occasional glycemia values of 147 ^ 13 mg/dl and
glycated hemoglobin values of 5.93 ^ 0.07%). Both
values were different from non-diabetic Wistar rats
(P , 0:001; n ¼ 5).
After isolation of the cardiac mitochondrial frac-
tion, we assessed mitochondrial respiratory par-
ameters. The values obtained for the RCR were a
good indication of mitochondrial integrity (Table 2).
No differences between groups were observable in the
RCR value, although we detected significant
decreases in state 4 respiration in VitE, CoQ and
CoQ þ VitE-treated groups when compared with
the vehicle (Table 2). No differences were found
Table 1
Animal weight determination and biochemical analyses in occasional glycaemia and glycated haemoglobin
Oil (control) Vitamin E Coenzyme Q10 Coenzyme Q10 þ Vitamin E
Final body weight (g) 235.30 ^ 6.35 242.5 ^ 4.25 232.60 ^ 9.0 237.70 ^ 7.41
Weight gain (g) 178.0 ^ 6.47 182.60 ^ 5.70 171.96 ^ 5.80 175.10 ^ 4.03
Occasional glycaemia (mg/dl) 147 ^ 13 164 ^ 16 156 ^ 10 145 ^ 7
HbA1c (%) 5.93 ^ 0.07 5.8 ^ 0.14 5.65 ^ 0.09 5.64 ^ 0.11
The results are presented as mean ^ SEM of 5–8 independent experiments. Occasional glycaemia was measured at the time of animal
sacrifice. HbA1c, glycated haemoglobin.
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regarding state 3. The significant increase in the
ADP/O value in the VitE-treated animals (Table 2), is
worthy of attention and will be confirmed later with a
different technique. We determined the levels of
CoQ10 and VitE in the cardiac mitochondrial fraction
in order to determine the enrichment of those fractions
(Table 2). Surprisingly, only a mitochondrial enrich-
ment on CoQ10 was found in the VitE group. No other
differences were found. When measuring Coenzyme
Q9 (data not shown), no differences were again found.
Mitochondrial generation of transmembrane elec-
tric potential ðDCÞ was also determined in the four
experimental groups, as well as the ADP-induced
depolarization. No differences were again observable
between treatment groups (Table 2).
Measurements of the phosphorylation lag phase
provided valuable information. This parameter rep-
resents the time required for the mitochondrial
suspension to phosphorylate the amount of ADP
added to the reaction buffer. As is apparent (Fig. 1),
heart mitochondria from VitE-treated animals showed
a shorter lag-phase, which signifies a faster phos-
phorylation activity. Nevertheless, VitE, when co-
administrated with CoQ10, did not have the same
effect.
One particular aspect of mitochondrial dysfunction
is a reduction in calcium loading capacity. We
performed experiments in which the objective was
to determine the amount of TPPþ that heart
mitochondria from the four groups were capable of
loading in a buffer containing calcium. The mito-
chondrial permeability transition (MPT) is a condition
that acts as a redox sensor of the inner mitochondrial
environment. As described later, increased mitochon-
drial oxidative stress can induce the MPT in the
presence of calcium. Our experiments were a way of
indirectly assessing mitochondrial ability to load
calcium by measuring the maximal mitochondrial
retention of TPPþ. An early occurrence of the
calcium-dependent MPT would be related to a lower
TPPþ accumulation (since it would lead to membrane
depolarization and inability to accumulate the TPP
cation). Rats treated with VitE showed a higher ability
to generate membrane potential when incubated
with calcium (100 mM, Fig. 2). In contrast, cardiac
Table 2
Mitochondrial function parameters and biochemical analyses from the four experimental groups
Oil (control) Vitamin E Coenzyme Q10 Coenzyme Q10 þ Vitamin E
State 4 (natms O/min/mg prot) 110.4 ^ 5.8 73.7 ^ 5.0# 82.3 ^ 4.7* 89.1 ^ 10.0*
State 3 (natms O/min/mg prot) 296.0 ^ 19.9 224.7 ^ 31.9 236.8 ^ 26.0 247.0 ^ 33.2
RCR 2.7 ^ 0.1 2.6 ^ 0.1 2.6 ^ 0.1 2.6 ^ 0.1
ADP/O 1.4 ^ 0.1 1.9 ^ 0.2* 1.6 ^ 0.1 1.6 ^ 0.2
DC (mV) 230.4 ^ 1.2 233.3 ^ 1.0 232.1 ^ 1.7 225.5 ^ 4.8
ADP-induced depolarization (mV) 41.0 ^ 2.20 35.6 ^ 2.6 39.2 ^ 1.12 42.71 ^ 5.17
Coenzyme Q10 (pmol/mg) 124.10 ^ 11.04 187.2 ^ 14.77* 148.48 ^ 8.78 178.40 ^ 20.33
Vitamin E (nmol/mg) 1.38 ^ 0.10 1.30 ^ 0.06 1.11 ^ 0.08 1.32 ^ 0.10
The results are presented as mean ^ SEM of 5–8 independent experiments. ADP (100 nmol) was added to induce state 3 respiration. The
Respiratory Control Ratio (RCR) was calculated as the ratio between state 3 and state 4 respiration. The ADP/O was calculated as the number of
nmol ADP phosphorylated by natom oxygen consumed. *, P , 0:05 vs. oil; #, P , 0:01 vs. oil.
Fig. 1. Phosphorylative lag phase. Lag phase was measured as
described in Section 2. The results are presented as mean ^ SEM of
5–8 independent experiments. *P , 0:05 vs. VitE, ** P , 0:001
vs. control (oil-injected animals).
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mitochondria isolated from rats injected simul-
taneously with VitE and CoQ10 did not differ from
controls regarding this parameter.
4. Discussion
Despite many studies on the impact of antioxidants
on diabetic complications (for a review see Lamson
and Plaza, 2002), no studies are available concerning
the effects of such compounds on cardiac mitochon-
drial performance in diabetic GK rats. To study this
subject, we used GK rats, an animal model for
hereditary diabetes and moderate hyperglycemia
(Goto et al., 1975, 1988). We injected CoQ10 and
VitE, alone and in combination, and determined
changes in cardiac mitochondrial function.
From our results, VitE appeared more promising
regarding the improvement of mitochondrial function,
despite the fact that no changes whatsoever were
observed in the diabetic phenotype. Three aspects of
mitochondrial function were ameliorated in VitE
injected animals. Two of them were complementary
and were related to the mitochondrial phosphorylative
system. It appears that heart mitochondria from VitE-
injected animals were able to phosphorylate ADP in a
faster way (as revealed by the shorter lag phase),
although no changes in the RCR value were obtained,
and by consuming a lower amount of oxygen in the
process (revealed by the ADP/O ratio, a measurement
of the mitochondrial phosphorylation efficiency). The
other aspect concerned an increased ability to
generate membrane potential in the presence of
supra-physiological calcium concentrations. It is
noticeable that the effect of VitE was absent when
animals were injected with both compounds, which
was a rather unexpected result.
In a first analysis, the most surprising result was
the absence of mitochondrial accumulation of
CoQ10 in CoQ10-injected animals (Table 2).
Nevertheless, it is not the first time that such a
result has been observed. Ibrahim et al. (2000)
observed that CoQ10 oral administration did not
alter the levels of that compound in the heart.
Nevertheless, the authors observed a dose-dependent
sparing effect of VitE in CoQ10 levels in several
organs, but not in the heart. From Table 2, one can
see that the administration of VitE did not cause an
increase of VitE in the cardiac tissue but caused
instead an increase of CoQ10. Coenzyme Q9, in
accordance with previous works (Ibrahim et al.,
2000) was also not affected (data not shown). It has
previously been demonstrated that oxidative stress
inside mitochondria is inversely proportional to the
membrane concentration of CoQ10 (Lass et al.,
1999). From our results, we can predict that the
protective effects of VitE administration as observed
were mediated by a sparing effect on CoQ10, as
described by other authors (Kagan et al., 1990).
Some literature reports that VitE enhances the
biosynthesis of coenzyme Q (Donchenko et al.,
1991), which can, in fact, explain the increased
amounts of CoQ10 found in the mitochondrial
membranes of VitE injected animals. It was also
previously proposed (Fontaine and Bernardi, 1999)
that CoQ10 is inhibitory for MPTP opening, which
may help to explain the increment in mitochondrial
calcium loading capacity. As far the more efficient
ADP phosphorylation seen in VitE-injected animal
Fig. 2. TPPþ accumulation in the presence of 100 mM calcium,
measured by using a TPPþ-selective electrode. Sequential additions
of 0.5 mM TPPþ were made in order to calibrate the system.
Succinate was added to the mitochondrial suspension after a total of
3 mM TPPþ in the buffer. In each assay, the calibration was used to
calculate the TPPþ accumulated inside mitochondria in the presence
of calcium. Succinate was the substrate used as this allowed a fully
reduced pool of pyridine nucleotides. The results are presented as
mean ^ SEM of 5–8 independent experiments. * P , 0:05 vs.
VitE, þ P , 0:001 vs. control (oil-injected animals).
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is concerned, the mechanism is still unclear,
although some previous reports in the literature
confirm that in vitro CoQ supplementation may
indeed increase the efficiency of oxidative phos-
phorylation in isolated heart mitochondria (Battino
et al., 1990). Although we did not explore this
matter in more detail, it appears that the increased
phosphorylative efficiency in the presence of VitE is
not directly related to the presence of a hypergly-
cemic condition. In fact, the effect appears to be due
to other mechanisms than mere membrane inter-
actions of VitE since VitE, CoQ and CoQ þ VitE
all caused a decrease in state 4 respiration which
can be indicative of decrease in inner membrane
permeability to protons. From those three groups
only VitE was able to increase the ADP/O value. A
logical question is why VitE and CoQ10 did not
show synergistic effects when administrated
together. In fact, we observed that the simultaneous
administration of both compounds had no effect
whatsoever on the several mitochondrial parameters
measured. Although rather unexpected, a previous
report in the literature suggested that CoQ and VitE
could compete regarding intestinal absorption when
administrated together (Kaikkonen et al., 2002).
Although the heart is an organ known to be
affected during diabetes-associated complications
(Pierce et al., 1997; Chaudhuri and Hopkins,
2000), it was suggested that cardiac dysfunction is
dependent upon the degree of diabetes (Feuvray and
Lopaschuk, 1997; Paulson, 1997). In fact, we
demonstrated that GK rats have a higher calcium
loading capacity by means of lower calcium gating
of the MPT (Oliveira et al., 2001), which could
work as an advantage to those animals. The MPT is
linked to the formation and opening of protein pores
(the MPT pores) in the inner mitochondrial
membrane (Zoratti and Szabo`, 1995). MPT pore
opening can be caused by excessive mitochondrial
calcium accumulation and oxidative stress gener-
ation (Kowaltowski et al., 2001), and can lead
ultimately to cell death (Kroemer and Reed, 2000).
We propose that the recurrent hyperglycemia and
oxidative stress in the GK rats (Ihara et al., 1999)
could trigger adaptation mechanisms in order to
counteract that condition (Oliveira et al., 2001),
which would lead to increased mitochondrial func-
tion (as described above). Thus, it is predictable that
an extra supplementation of some antioxidants will
not have such a marked effect since mitochondrial
function in this aspect is already ameliorated. This is
in contrast to what we would expect to see in other
models of more severe diabetes, in which oxidative
defences and mitochondrial function may be com-
promised. Furthermore, as discussed, the heart
appears not to accumulate exogenously added VitE
and CoQ10 (Ibrahim et al., 2000), despite the idea
that Vitamin E supplementation may help increase
endogenous CoQ10 levels in that tissue (Ibrahim
et al., 2000).
We propose that for milder forms of diabetes in
animal models, where apparent mitochondrial adap-
tations appear to have occurred, the administration of
antioxidants will have a very limited positive impact
on mitochondrial function, not only due to small
cardiac tissue enrichment but also to the already
ameliorated mitochondrial function. Nevertheless,
VitE showed a more encouraging result. Studies
remain to be done in animal models for severe
diabetes, such as the streptozotocin-injected animal,
where dysfunctional mitochondrial function is
observed (Kristal et al., 1997). Despite VitE positive
impact, it did not reverse the diabetic phenotype found
in GK rats.
In conclusion, in all forms of administration, VitE
showed a modest positive impact, possibly through a
sparing effect on CoQ10 or by increasing its
biosynthesis, as previously reported (Donchenko
et al., 1991). This study also demonstrated the
administration of CoQ10 and VitE to GK rats does
not result in a clear direct enrichment of the
compounds in the cardiac mitochondrial fraction and
appears not advantageous in the management of
diabetes complications.
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